Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Pediatric Rheumatology · LACC1-Associated Arthritis

How LACC1-Associated Arthritis is Diagnosed

At a Glance

LACC1-associated juvenile arthritis is diagnosed by finding pathogenic or likely pathogenic variants in both copies of the LACC1 gene, together with early severe arthritis. Parental testing can clarify inheritance, but a variant of uncertain significance alone does not confirm the diagnosis.

Because LACC1-associated juvenile arthritis is so rare and looks like other forms of childhood arthritis, it is almost always diagnosed through genetic sequencing. This process involves looking at your child’s DNA to find specific changes in the LACC1 gene that prevent it from working correctly [1][2].

Doctors often order these tests when a child has severe arthritis that starts very early—often before age two—and doesn’t respond to typical treatments as expected [3][1].

Understanding the Genetic Result

When you receive a genetic report, it will likely use technical terms to describe how your child inherited the condition. LACC1 follows an autosomal recessive inheritance pattern [1][4]. This means a child must have two pathogenic variants—one from each parent—to develop the disease. Because parents are usually unaffected carriers, there is often no previous family history of the disease, though consanguinity (blood relations) or affected siblings can be clues.

A diagnosis requires biallelic pathogenic or likely pathogenic variants interpreted alongside clinical symptoms. A “Variant of Uncertain Significance” (VUS) is not diagnostic. The report may use one of two terms to describe the findings:

  • Homozygous: Your child inherited the exact same pathogenic variant from both parents. This is more common in families where the parents share a common ancestor [1][4].
  • Compound Heterozygous: Your child has two different pathogenic variants in the LACC1 gene. These usually need to be demonstrated to be in trans (on opposite chromosomes), which is typically confirmed through parental testing [1][5].

In both cases, the result is the same: the body cannot produce a functional version of the FAMIN protein, which leads to the immune system misfiring [2].

LACC1 vs. Conventional JIA

Before genetic testing, most children with this condition are diagnosed with one of two “conventional” types of Juvenile Idiopathic Arthritis (JIA). However, there are key differences that genetic testing helps clarify:

Feature Conventional Systemic JIA RF-Negative Polyarticular JIA LACC1-Associated Arthritis
Cause Complex (multiple genes + environment) Complex (multiple genes + environment) Monogenic (one gene: LACC1) [1]
Inheritance Rarely runs in families Rarely runs in families Autosomal recessive; often no prior family history [4]
Joint Damage Varies Can be slow to progress Often highly erosive and fast-moving [3]
Other Signs High fevers, rashes Mainly joint-focused Can have fevers AND limb swelling (lymphedema) [1]

Why the Diagnosis Matters

Identifying the LACC1 gene change is more than just giving a name to the condition. It confirms that your child has a monogenic autoinflammatory disorder. This shift in diagnosis is crucial because it tells your doctors that the “blueprint” for your child’s immune system is what is causing the inflammation [2].

It is important to note that families can have variable expressivity. This means that even if two people have the same LACC1 mutation, their symptoms might look different. In very rare cases, researchers have even found individuals with biallelic variants who show no symptoms at all, possibly because other parts of their genetic code are “protecting” them from the disease, though this area remains under study [2][6].

Recurrence Risk: If both parents are confirmed carriers, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being neither. Testing other relatives should be coordinated with a genetics professional or genetic counselor.

Common questions in this guide

How is LACC1-associated juvenile arthritis diagnosed?
Doctors usually combine a child's early, severe arthritis pattern with genetic sequencing. The diagnosis generally requires disease-causing or likely disease-causing changes in both copies of LACC1; a variant of uncertain significance alone does not confirm the condition.
What does an autosomal recessive LACC1 result mean?
It means a child inherited one disease-causing LACC1 change from each parent. Parents are often healthy carriers, so a child can be affected even when there is no known family history.
What do homozygous and compound heterozygous mean on the report?
Homozygous means the same LACC1 change is present in both copies of the gene. Compound heterozygous means there are two different changes, one on each copy; parental testing can confirm that they are on opposite chromosomes.
Why might parents need testing after two LACC1 variants are found?
Parental testing can show whether two different LACC1 variants were inherited one from each parent, a pattern called being in trans. This helps confirm that both gene copies are affected and supports an autosomal recessive diagnosis.
What is the chance of LACC1-associated arthritis in another pregnancy?
If both parents carry a disease-causing LACC1 variant, each pregnancy has a 25% chance of being affected, a 50% chance of being an unaffected carrier, and a 25% chance of inheriting neither variant. A genetic counselor can explain testing and reproductive options for your family.
How is LACC1-associated arthritis different from conventional juvenile arthritis?
LACC1-associated arthritis is caused by changes in a single gene and follows an autosomal recessive inheritance pattern, while conventional juvenile idiopathic arthritis usually has multiple genetic and environmental influences. LACC1-associated disease often begins very early and may cause rapidly progressive joint damage, fevers, or limb swelling.
Can a variant of uncertain significance prove that my child has LACC1-associated arthritis?
No. A variant of uncertain significance means there is not enough evidence to know whether the change causes disease, so it should not be used alone to confirm the diagnosis. Your child's genetic and clinical specialists can interpret the result with the rest of the evaluation.

Get notified when new evidence is published on juvenile arthritis due to defect in LACC1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    New or vanishing frontiers: LACC1-associated juvenile arthritis.

    Al-Mayouf SM, Yateem M, Al-Dusery H, et al.

    International journal of pediatrics & adolescent medicine 2021; (8(1)):44-47 doi:10.1016/j.ijpam.2020.11.005.

    PMID: 33718577
  2. 2

    A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.

    Alblooshi H, Mustafa N, Khalam AA, et al.

    Human genomics 2025; (19(1)):85.

    PMID: 40713900
  3. 3

    [Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].

    Knieper AM, von Stuckrad ASL, Minden K, et al.

    Zeitschrift fur Rheumatologie 2024; (83(1)):4-14 doi:10.1007/s00393-023-01442-2.

    PMID: 37921883
  4. 4

    Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review.

    Wu Y, Wang S, Yin W, et al.

    Molecular genetics & genomic medicine 2023; (11(7)):e2175 doi:10.1002/mgg3.2175.

    PMID: 37186377
  5. 5

    Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course.

    Kallinich T, Thorwarth A, von Stuckrad SL, et al.

    Pediatric rheumatology online journal 2016; (14(1)):63 doi:10.1186/s12969-016-0124-2.

    PMID: 27881174
  6. 6

    LACC1 deficiency leading to juvenile arthritis and anemia.

    He T, Wang L, Huang X, et al.

    Clinical immunology (Orlando, Fla.) 2024; (265()):110290 doi:10.1016/j.clim.2024.110290.

    PMID: 38944365

This page explains how LACC1-associated juvenile arthritis is diagnosed for educational purposes and does not replace professional medical advice. A pediatric rheumatologist, genetics professional, or genetic counselor should interpret your child's results and discuss testing for relatives.